CU6 9.43% $5.57 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-8

  1. 71 Posts.
    lightbulb Created with Sketch. 48
    Hi Ma20,

    I am sure I am stating the obvious here to everyone but the principal investigator of Cobra is Dr Neil Shore who is the Chief Medical Officer, Surgical Oncology and Urology - Genesis Care, US.
    Genesis did get into financial difficulty and unwillingly had to liquidate assets at the time. Clarity was easily accessible for the fire sale at the time, much to Neil's disgust. Genesis still has a large interest in what Clarity is delivering, as a larger user of the technology once developed.

    sorry if I am stating the obvious.
    Who knows, Genesis has turned the corner and is starting to show better results financially and may drive back in?
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$5.57
Change
0.480(9.43%)
Mkt cap ! $1.735B
Open High Low Value Volume
$5.20 $5.57 $5.16 $14.63M 2.711M

Buyers (Bids)

No. Vol. Price($)
1 6146 $5.57
 

Sellers (Offers)

Price($) Vol. No.
$5.60 6194 4
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.